Published in J Control Release on February 23, 2008
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev (2012) 3.34
Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater (2009) 2.44
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine (2011) 1.26
In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Mol Pharm (2011) 1.17
Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech (2010) 1.16
Liquid-liquid two-phase systems for the production of porous hydrogels and hydrogel microspheres for biomedical applications: A tutorial review. Acta Biomater (2010) 1.07
Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol (2010) 1.05
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique. EJNMMI Res (2012) 0.96
Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.91
Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules. Antimicrob Agents Chemother (2013) 0.87
Nanopod formation through gold nanoparticle templated and catalyzed cross-linking of polymers bearing pendant propargyl ethers. J Am Chem Soc (2010) 0.85
Low-energy nanoemulsification to design veterinary controlled drug delivery devices. Int J Nanomedicine (2010) 0.83
Spontaneous formation of water droplets at oil-solid interfaces. Langmuir (2010) 0.82
Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature. Nanoscale Res Lett (2013) 0.81
Ease of synthesis, controllable sizes, and in vivo large-animal-lymph migration of polymeric nanoparticles. ChemMedChem (2010) 0.81
Optimization of ultrasonic emulsification conditions for the production of orange peel essential oil nanoemulsions. J Food Sci Technol (2014) 0.79
Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation. Int J Nanomedicine (2015) 0.78
Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections. Int J Nanomedicine (2015) 0.77
"The Good, the Bad and the Ugly" of Chitosans. Mar Drugs (2016) 0.77
Control of polymeric nanoparticle size to improve therapeutic delivery. J Control Release (2015) 0.77
Microencapsulation of nanoemulsions: novel Trojan particles for bioactive lipid molecule delivery. Int J Nanomedicine (2011) 0.77
Integrity of lipid nanocarriers in bloodstream and tumor quantified by near-infrared ratiometric FRET imaging in living mice. J Control Release (2016) 0.77
Trojan microparticles for drug delivery. Pharmaceutics (2012) 0.76
Modeling and optimization of nanoemulsion containing Sorafenib for cancer treatment by response surface methodology. Chem Cent J (2017) 0.75
Marine polysaccharides in microencapsulation and application to aquaculture: "from sea to sea". Mar Drugs (2011) 0.75
A new nano-engineered hierarchical membrane for concurrent removal of surfactant and oil from oil-in-water nanoemulsion. Sci Rep (2016) 0.75
Inhibition of the enhancement of infection of human immunodeficiency virus by semen-derived enhancer of virus infection using amyloid-targeting polymeric nanoparticles. ACS Nano (2015) 0.75
Nano- and microdelivery systems for marine bioactive lipids. Mar Drugs (2014) 0.75
Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin. Beilstein J Org Chem (2015) 0.75
Bottom-up formation of dodecane-in-water nanoemulsions from hydrothermal homogeneous solutions. Angew Chem Int Ed Engl (2013) 0.75
PLA micro- and nano-particles. Adv Drug Deliv Rev (2016) 0.75
Firstborn microcrystallization method to prepare nanocapsules containing artesunate. Int J Nanomedicine (2010) 0.75
Nanomedicine approaches for corneal diseases. J Funct Biomater (2015) 0.75
Liquid crystal nanoparticle formulation as an oral drug delivery system for liver-specific distribution. Int J Nanomedicine (2016) 0.75
A new application of lipid nanoemulsions as coating agent, providing zero-order hydrophilic drug release from tablets. J Drug Deliv (2012) 0.75
Bacterial-Derived Polymer Poly-y-Glutamic Acid (y-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical Applications. Int J Mol Sci (2017) 0.75
Preparation and Characterization of Three Tilmicosin-loaded Lipid Nanoparticles: Physicochemical Properties and in-vitro Antibacterial Activities. Iran J Pharm Res (2016) 0.75
Nanoparticles from renewable polymers. Front Chem (2014) 0.75
Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting. Mar Drugs (2016) 0.75
Nanoemulsion: an advanced mode of drug delivery system. 3 Biotech (2014) 0.75
Effect of O/W process parameters on Crataegus azarolus L nanocapsule properties. J Nanobiotechnology (2013) 0.75
Effect of Palm or Coconut Solid Lipid Nanoparticles (SLNs) on Growth of Lactobacillus plantarum in Milk. Korean J Food Sci Anim Resour (2015) 0.75
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials (2008) 2.43
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer. N Engl J Med (2013) 2.38
Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials (2006) 1.94
The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera. Blood (2007) 1.83
Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release (2006) 1.76
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res (2007) 1.69
Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab (2002) 1.60
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials (2009) 1.59
Physico-chemical stability of colloidal lipid particles. Biomaterials (2003) 1.44
Active targeting of brain tumors using nanocarriers. Biomaterials (2007) 1.42
Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis. Blood (2006) 1.35
Structure and function of a mitochondrial late embryogenesis abundant protein are revealed by desiccation. Plant Cell (2007) 1.34
Melanin is an essential component for the integrity of the cell wall of Aspergillus fumigatus conidia. BMC Microbiol (2009) 1.34
A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res (2002) 1.22
Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther (2003) 1.15
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond) (2010) 1.10
Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials (2009) 1.08
Perfusional deficit and the dynamics of cerebral edemas in experimental traumatic brain injury using perfusion and diffusion-weighted magnetic resonance imaging. J Neurotrauma (2007) 1.04
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS One (2011) 1.02
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials (2007) 1.00
Passive and active tumour targeting with nanocarriers. Curr Drug Discov Technol (2011) 1.00
Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. J Biomed Mater Res B Appl Biomater (2008) 1.00
High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinoma. Lab Invest (2008) 0.99
A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm Res (2002) 0.99
Biological consequences of petite mutations in Candida glabrata. J Antimicrob Chemother (2005) 0.98
Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. Int J Pharm (2007) 0.98
Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis. Endocr Relat Cancer (2010) 0.97
Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death. J Immunol (2007) 0.95
A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials (2013) 0.95
Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1/rd1 mouse. Mol Vis (2005) 0.95
Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Eur J Pharm Biopharm (2009) 0.92
Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Nanomedicine (2012) 0.90
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Eur J Pharm Biopharm (2002) 0.90
Brain targeting using novel lipid nanovectors. J Control Release (2007) 0.90
Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials (2010) 0.90
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm (2008) 0.90
Strategies for drug delivery to the human inner ear by multifunctional nanoparticles. Nanomedicine (Lond) (2011) 0.90
The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials (2010) 0.90
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J Control Release (2004) 0.89
The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials (2009) 0.89
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. J Neurooncol (2009) 0.89
Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery (2005) 0.89
Drug delivery into the brain using poly(lactide-co-glycolide) microspheres. Expert Opin Drug Deliv (2005) 0.88
Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Pharm Res (2011) 0.88
New lipid nanocapsules exhibit sustained release properties for amiodarone. J Control Release (2002) 0.88
Toxicological study and efficacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice. Pharm Res (2010) 0.87
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials (2011) 0.87
Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface. Electrophoresis (2005) 0.86
Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Eur J Pharm Biopharm (2011) 0.86
Dynamics of cerebral edema and the apparent diffusion coefficient of water changes in patients with severe traumatic brain injury. A prospective MRI study. Eur Radiol (2006) 0.86
Gemcitabine versus Modified Gemcitabine: a review of several promising chemical modifications. Mol Pharm (2012) 0.86
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution. Eur J Nucl Med Mol Imaging (2006) 0.86
Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Int J Pharm (2010) 0.86
Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm (2004) 0.85
A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging. J Control Release (2013) 0.85
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model. Int J Pharm (2010) 0.85
Surveillance of intestinal colonization and of infection by vancomycin-resistant enterococci in hospitalized cancer patients. Clin Microbiol Infect (1996) 0.85
Pegylated nanocapsules produced by an organic solvent-free method: Evaluation of their stealth properties. Pharm Res (2006) 0.85
The influence of lipid nanocapsule composition on their size distribution. Eur J Pharm Sci (2003) 0.83
188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma. Nucl Med Commun (2004) 0.83
Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats. Neurosci Lett (2004) 0.83
Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. Nanomedicine (Lond) (2009) 0.83
Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. Int J Nanomedicine (2011) 0.83
ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform. Cell Cycle (2013) 0.83
Response of ovarian carcinomas to gefitinib-carboplatin-paclitaxel combination is not associated with EGFR kinase domain somatic mutations. Int J Cancer (2006) 0.83
Influence of 5-fluorouracil-loaded microsphere formulation on efficient rat glioma radiosensitization. Pharm Res (2004) 0.82
Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules. Langmuir (2009) 0.81
In vitro study of GDNF release from biodegradable PLGA microspheres. J Control Release (2004) 0.81
Therapeutic effectiveness of novel 5-fluorouracil-loaded poly(methylidene malonate 2.1.2)-based microspheres on F98 glioma-bearing rats. Cancer (2003) 0.81
Disruption of Candida albicans IFF4 gene involves modifications of the cell electrical surface properties. Colloids Surf B Biointerfaces (2007) 0.81
Baclofen-loaded microspheres in gel suspensions for intrathecal drug delivery: in vitro and in vivo evaluation. Eur J Pharm Biopharm (2005) 0.81
Treatment efficacy of DNA lipid nanocapsules and DNA multimodular systems after systemic administration in a human glioma model. J Gene Med (2012) 0.81
Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants. Biomaterials (2005) 0.81
Stereotaxic implantation of 5-fluorouracil-releasing microspheres in malignant glioma. Cancer (2004) 0.81
Salting-out effect induced by temperature cycling on a water/nonionic surfactant/oil system. J Phys Chem B (2007) 0.81
The influence of headgroup structure and fatty acyl chain saturation of phospholipids on monolayer behavior: a comparative rheological study. Chem Phys Lipids (2007) 0.81
Lipid nanocapsules for intracellular drug delivery of anticancer drugs. J Nanosci Nanotechnol (2007) 0.81
Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft. Pharm Res (2009) 0.80
In vitro expansion of human glioblastoma cells at non-physiological oxygen tension irreversibly alters subsequent in vivo aggressiveness and AC133 expression. Int J Oncol (2011) 0.80
Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. Int J Pharm (2010) 0.80
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas. J Control Release (2008) 0.80
Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int J Nanomedicine (2013) 0.79
The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells. Biomaterials (2013) 0.79